Downregulation of PKD3 inhibited the invasion, migration and proliferation of OSCC in vitro; reduced tumour growth and metastasis in vivo; and decreased the expression of mesenchymal markers while increasing that of E-cadherin. The gene discussed is PRKD3; the disease is neoplasm.